Search results
Opinion | Lina Khan’s Failed FTC Experiment
The Wall Street Journal· 6 days agoBad management, poor strategy and disregard for norms have foiled her plan to refashion antitrust law.
Antitrust agencies are relying on consumers to report anticompetitive behavior. That trust might be...
Healthcare Dive via Yahoo Finance· 7 days agoRegulators want consumers to flag business practices harming market health in the healthcare sector,...
Opinion | How the FTC Protects Patients in Healthcare
MedPage Today· 6 days agoIn Part 1 of this exclusive video interview, MedPage Today editor-in-chief Jeremy Faust, MD, and ...
Biden's radical trade commission wages war on American AI
Fox News· 7 days agoThe Federal Trade Commission (FTC), under Chairwoman Lina Khan, shows no signs of relenting in its...
Will The FTC Reinvigorate An Antiquated Law That Raises Prices?
Forbes· 7 days agoThe FTC may wish to consider the major downsides of RPA prosecutions before it takes action. The...
Opinion | FTC Puts Pharmacy Benefit Managers, Private Equity in the Crosshairs
MedPage Today· 3 days agoIn Part 2 of this exclusive video interview, MedPage Today editor-in-chief Jeremy Faust, MD, and ...
Private equity in health care: three takeaways going forward
Reuters· 3 days agoFederal agencies are turning up the volume on their warnings to private equity (PE) investors to...
FTC Pioneers Novel Remedies in the Exxon/Pioneer Merger | JD Supra
JD Supra· 5 days ago...authored a joint dissenting statement expressing concern that the FTC is “leveraging its merger enforcement authority to extract a consent from Exxon” without articulating how the transaction violates Section 7 of the Clayton Act.3 FTC Chair Lina Khan and Commissioners Alvaro Bedoya and Rebecca...
Illinois public officials seek greater oversight of prescription drug 'middlemen'
ABC 7 Chicago· 4 days agoAs state lawmakers hold hearings targeting the role of pharmacy benefit managers - an influential...